7-Bromopyrrolo [2,1-f][1,2,4] triazin-4-amine CAS 937046-98-5 Remdesivir Entèmedyè COVID-19
Manifakti Komèsyal Pwovizyon pou Remdesivir ak entèmedyè ki gen rapò ak kalite siperyè
Remdesivir CAS 1809249-37-3
2-Ethyl-1-butanol CAS 97-95-0
Trimethylsilil Cyanide CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Ethylbutil ((S)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester CAS 1354823-36-1
(S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Remdesivir metabolit (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Entèmedyè CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo [2,1-f][1,2,4] triazin-4-amine CAS 937046-98-5
Pyrrolo [1,2-F][1,2,4] Triazin-4-Amine CAS 159326-68-8
4-Amino-7-yodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Non Chimik | 7-Bromopyrrolo [2,1-f][1,2,4] triazin-4-amine |
Sinonim | 4-Amino-7-bromopyrrolo [2,1-f][1,2,4] triazin;Remdesivir enpurte 2 |
Nimewo CAS | 937046-98-5 |
Nimewo CAT | RF-PI305 |
Estati Stock | Nan stock, pwodiksyon echèl jiska dè santèn de kilogram |
Fòmil molekilè | C6H5BrN4 |
Pwa molekilè | 213.04 |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Limyè jòn poud |
Enfrawouj Spectrum | Konfòm ak estrikti |
RMN | Konfòm ak estrikti |
Pite | ≥97.0% |
Pèt sou siye | ≤1.0 |
Single enpurte | ≤1.0% |
Metal lou | ≤20ppm |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Remdesivir (CAS 1809249-37-3) |
Pake: Boutèy, sak papye aliminyòm, tanbou katon, 25kg / tanbou, oswa selon kondisyon kliyan an.
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè, imidite ak ensèk nuizib.
7-Bromopyrrolo [2,1-f][1,2,4] triazin-4-amine (CAS 937046-98-5) se yon entèmedyè nan Remdesivir (CAS 1809249-37-3).Remdesivir se yon dwòg antiviral ki gen aktivite kont kowonaviris sendwòm respiratwa egi grav 2 (SARS-CoV-2).Remdesivir (ke yo rele tou Veklury oswa GS-5734) se yon inibitè RNA polymerase analòg nukleotid SARS-CoV-2 ki endike pou granmoun ak pasyan pedyatrik (ki gen 12 an oswa plis epi ki peze omwen 40 kg) pou tretman maladi coronavirus 2019. (COVID-19) ki mande entène lopital.Remdesivir ta dwe sèlman administre nan yon lopital oswa nan yon anviwònman swen sante ki kapab bay swen egi ki konparab ak swen lopital pou pasyan ki entène.Remdesivir te okòmansman devlope kòm yon anti-viris kont viris Ebola, men depi yo te montre yo diminye chaj viral nan yon kantite viris RNA ki gen ladan viris respiratwa syncytial (RSV) ak β-coronavirus tankou SARS-CoV, MERS-CoV, ak ajan kozatif COVID-19, SARS-CoV-2.